Intravenous Hydromorphone for the Treatment of Acute Pain

Recruiting now · Phase 1/Phase 2

Conditions studied: Acute Chest Pain

In brief

To observe the efficacy and safety of hydromorphone in the treatment of acute chest pain, and to explore the potential advantages of hydromorphone for analgesia in patients with acute chest pain, so as to provide more theoretical basis for individualized analgesia and rapid recovery in patients with acute chest pain.

Key facts

Study ID
NCT06949059
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
People needed
30
Starts
2025-01-01
Expected to finish
2027-12-31
Last updated by the study team
2025-11-17

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.